Evidence map›Paper›PMID 29069814›Full record

ArticleOncotarget2017

Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches.

Sandra Perdomo, Patrice H Avogbe, Matthieu Foll, Behnoush Abedi-Ardekani, Violeta Lescher Facciolla, Devasena Anantharaman, Priscilia Chopard, Florence Le Calvez-Kelm, Marta Vilensky, Jerry Polesel and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. MutatedBiomolecules · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 8 countries.

Sandra Perdomo *International Agency for Research on Cancer (IARC), Lyon 69372, France.
Patrice H Avogbe *International Agency for Research on Cancer (IARC), Lyon 69372, France.
Matthieu FollInternational Agency for Research on Cancer (IARC), Lyon 69372, France.
Behnoush Abedi-ArdekaniInternational Agency for Research on Cancer (IARC), Lyon 69372, France.
Violeta Lescher FacciollaDepartamento de Saúde Coletiva, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo CEP01221-020, Brazil.
Devasena AnantharamanInternational Agency for Research on Cancer (IARC), Lyon 69372, France.
Priscilia ChopardInternational Agency for Research on Cancer (IARC), Lyon 69372, France.
Florence Le Calvez-KelmInternational Agency for Research on Cancer (IARC), Lyon 69372, France.
Marta VilenskyInstituto Angel Roffo, Buenos Aires C1417DTB, Argentina.
Jerry PoleselCRO Aviano National Cancer Institute, Aviano 33081, Italy.
Ivana HolcatovaCharles University, 1st Faculty of Medicine, Prague 116 36, Czech Republic.
Lorenzo SimonatoLaboratory of Public Health and Population Studies, University of Padova, Padova 35122, Italy.
Cristina CanovaLaboratory of Public Health and Population Studies, University of Padova, Padova 35122, Italy.
Pagona LagiouDepartment of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens 11527, Greece.
James D McKayInternational Agency for Research on Cancer (IARC), Lyon 69372, France.
Paul BrennanInternational Agency for Research on Cancer (IARC), Lyon 69372, France.
Centre International de Recherche sur le Cancer · FRUniversity of Padua · ITCentro di Riferimento Oncologico · ITCharles University · CZFaculdade de Ciências Médicas da Santa Casa de São Paulo · BRFundación Instituto Leloir · ARNational and Kapodistrian University of Athens · GR

Funding

World Health Organization 001
6 · The paper itself

Abstract

The use of non-invasive biomarkers such as circulating tumor DNA (ctDNA) in head and neck tumors may be of relevance in early diagnosis and eventually improved outcome. We evaluated two different approaches from two case series in Europe and South America including (i) targeted screening of ctDNA mutations, and (ii) detection of

Indexed as

cancerctDNAdetectionhead and neckmutation

Identifiers

PMID29069814
PMCPMC5641157
OpenAlexW2743878014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.